Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial

Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1, with no change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-11-18T02:50:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The Phase 1b study record for anetumab ravtansine is displayed with its study details, eligibility criteria, outcome measures, participating locations, and data-sharing information. The record indicates the study is completed and no longer recruiting.
    Difference
    86%
    Check dated 2026-11-11T01:54:46.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:15:24.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    A sitewide NIH banner about website changes was added, and the footer revision changed from v3.7.1 to v3.7.2; the page still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-21T00:18:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:27:11.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous detailed study content. Access to the study details is blocked on this page.
    Difference
    18%
    Check dated 2026-09-23T00:45:40.000Z thumbnail image

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.